Procalcitonin-guided antibiotic use in acute exacerbations of idiopathic pulmonary fibrosis

International Journal of Medical Sciences

Volumn 10, Issue 7, 2013, Pages 903-907

  Ding, Juanjuan ^a   Chen, Zhuochang ^a   Feng, Keqing ^a  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Acute exacerbation of idiopathic pulmonary fibrosis (AE IPF); Antibiotic use; Procalcitonin

Indexed keywords

ANTIBIOTIC AGENT; PROCALCITONIN;

AGED; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFICACY; DRUG USE; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; TREATMENT DURATION;

ACUTE EXACERBATION OF IDIOPATHIC PULMONARY FIBROSIS (AE-IPF).; ANTIBIOTIC USE; PROCALCITONIN;

AGED; ANTI-BACTERIAL AGENTS; CALCITONIN; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MALE; PROTEIN PRECURSORS;

EID: 84878404376     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.4972     Document Type: Article

References (21)

1. American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002;165:277-304.
2. Daniels CE, Yi ES, Ryu JH. Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis. Eur Respir J. 2008;32:170-174.
3. Hyzy R, Huang S, Myers J, et al. Acute exacerbation of idiopathic pulmonary fibrosis. Chest. 2007;132:1652-1658.
4. Briel M, Schuetz P, Mueller B, et al. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med. 2008;168:2000-2007.
5. Christ-Crain, Stolz D, Bingisser R, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med. 2006;174:84-93.
6. Gogos CA, Drosou E, Bassaris HP, et al. Pro-versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis. 2000; 181:176-180.
7. Burkhardt O, Ewig S, Haagen U, et al. Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection. Eur Respir J. 2010;36:601-7.
8. Collard HR, Moore BB, Flaherty KR, et al. Idiopathic Plumoary Fibrosis Clinical Research Network investigators. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2007; 176: 636-643.
9. Nylen ES, Muller B, Becker KL, et al. The future diagnostic role of procalcitonin levels: the need for improved sensitivity. Clin Infect Dis. 2003;36:823-824.
10. Antoniou KM, Cottin V. The challenge of acute exacerbation of pulmonary fibrosis. Respira-tion. 2012;83:13-6.
11. Schroeder S, Hochreiter M, Koehler T, et al. Procalcitonin(PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study. Langenbecks Arch Surg. 2009; 394: 221-6.
12. Simon-Blancal V, Freynet O, Nunes H, et al. Acute exacerbation of idiopathic pulmonary fibro-sis: outcome and prognostic factors. Respiration. 2012;83:28-35
13. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society(ATS), and the European Respiraotry Society(ERS) was adopted by the ATS board of directors,June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002;165:277-304.
14. Yokoyama T, Kondoh Y, Taniguchi H, et al. Noninvasive ventilation in acute exacerbation of idiopathic pulmonary fibrosis. Intern Med. 2010;49:1509-14.
15. Horita N, Akahane M, Okada Y, et al. Tacrolimus and Steroid Treatment for Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Intern Med. 2011;50:189-195.
16. Robert Hyzy, Steven Huang, Jeffrey Myers, et al. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Chest. 2007;132:1652-1658.
17. Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decision: past, present and future. BMC Med. 2011;9:107.
18. Simon-Blancal V, Freynet O, Nunes H, et al. Acute exacerbation of idiopathic pulmonary fibrosis: outcome and prognostic factors. Respiration. 2012;83:28-35.
19. Schuetz P, Albrich W, Christ-Crain M, et al. Procalcitonin for guidance of antibiotic therapy. Expert Rev Anti Infect Ther. 2010; 8:575-587.
20. Nobre V, Harbarth S, Graf JD, et al. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med. 2008; 177:498-505.
21. Kopterides P, Siempos II, Tsangaris I, et al. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med. 2010; 38:2229-41.